DSP Healthcare Fund - Regular Plan - IDCW
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 30-11-2018
AUM:
₹ 3,114.33 Cr
Expense Ratio
1.92%
Benchmark
BSE Healthcare TRI
ISIN
INF740KA1LE6
Minimum Investment
100.0
Minimum Topup
100.0
Minimum SIP Amount
100
Fund Manager
Mr. Chirag Dagli
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| DSP Healthcare Fund - Regular Plan - IDCW | -3.92 | 19.06 | 13.27 |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
23.454
Last change
-0.04 (-0.1876%)
Fund Size (AUM)
₹ 3,114.33 Cr
Performance
19.42% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved
Fund Manager
Mr. Chirag Dagli
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| CIPLA LIMITED EQ NEW FV RS.2/- | 8.69 |
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 8.48 |
| IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- | 7.73 |
| Globus Medical Inc | 6.78 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 6.52 |
| Illumina Inc | 6.07 |
| Sai Life Sciences Limited | 5.23 |
| GLAND PHARMA LIMITED EQ NEW FV Re.1/- | 5.09 |
| SUVEN PHARMACEUTICALS LIMITED EQ | 5.04 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 4.4 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 78.9 |
| Financial Services | 1.52 |
| Consumer Services | 0.5 |